Buildings 210, 211, 214 and 240 Cambridge Science Park
Buildings 214 and 240 are currently vacant and represent a significant re-development opportunity to deliver sustainable, flexible and technologically enabled “next generation” labs/workspaces. Amgen previously occupied both buildings and have since consolidated into Building 216 Cambridge Science Park. The buildings offer a combined total of over 50,000 sq ft and excellent car parking.
Buildings 210 and 211 Cambridge Science Park are lab-enabled properties currently occupied by Excalibur Healthcare and Cambridge Glycoscience. Predominantly situated over Ground + first floors, the asset provides c. 25,000 sq ft of lettable area.